Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 992 of 6351
-
New combo aims to cut rectal cancer treatment time and boost cure rates
Disease control OngoingThe treatment protocol proposed in this study is to perform short-term radiation therapy and 4 cycles of FOLFOX chemotherapy for neoadjuvant treatment of locally advanced rectal cancer. Compared to conventional chemoradiation therapy, the preoperative radiotherapy period is short…
Phase 2 • Sponsor: Kyungpook National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Immunotherapy plus chemo shows promise for tough sarcomas
Disease control Recruiting nowThe aim of this study was to investigate the efficacy and safety of CAV/IE chemotherapy combined with toripalimab versus CAV/IE chemotherapy alone in the treatment of patients with advanced or unresectable bone and soft tissue sarcomas who failed in standard treatment.
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Brain stimulation that adapts to sleep stages could restore rest in Parkinson's
Disease control CompletedParkinson's disease (PD) is a neurodegenerative disorder that leads to both motor and non-motor symptoms. Therapies have been developed that effectively target the motor symptoms. Non-motor symptoms are far more disabling for patients, precede the onset of motor symptoms by a dec…
Sponsor: University of Nebraska • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Radioactive seeds zaps tumors from the inside
Disease control Recruiting nowA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug cocktail shows promise for myeloma patients ineligible for transplant
Disease control OngoingA randomized Phase II clinical trial will be conducted to assess the impact on progression free survival (PFS) with the addition of ixazomib and daratumumab to lenalidomide as a maintenance treatment following induction with lenalidomide, ixazomib, dexamethasone, and daratumumab.…
Phase 2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a common arthritis drug ease skin woes in down syndrome?
Disease control CompletedPeople with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. …
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Malaria drug may boost melanoma immunotherapy
Disease control OngoingThis study will evaluate the safety, tolerability and efficacy (objective response rate) of using hydroxychloroquine (HCQ) in combination with nivolumab and ipilimumab or with nivolumab alone in subjects with advanced/metastatic melanoma.
Phase 1/2 • Sponsor: Ravi Amaravadi, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can reminders and education prevent cervical cancer? a new trial aims to find out.
Prevention OngoingThis trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appalachian states. Utilizing educational and promotional materials and electronic h…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
New MRI technique could spot dangerous placenta adhesions before delivery
Diagnosis Recruiting nowPlacenta Adhesion Abnormalities (PAA) are the consequence of an excessive invasion of the placenta within the myometrium. PAA are related to severe maternal pregnancy outcomes, especially in case of incidental discovery during delivery that increase the risk of intraoperative mas…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
Disease control Recruiting nowThis study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New radiation implant shows promise for tough pancreatic cancers
Disease control OngoingA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer.
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Bacteria armed with immune booster takes on tough pancreatic cancer
Disease control OngoingObjectives: Assess the efficacy of multiple dose oral administration of Saltikva, an attenuated strain of Salmonella Typhimurium expressing IL-2, in patients with metastatic pancreatic cancer on standard chemotherapy (either FOLFIRINOX or Gemcitabine/Abraxane and Saltikva). Stud…
Phase 2 • Sponsor: Salspera LLC • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New valve replacement could fix leaky hearts without cutting chest open
Disease control OngoingThe objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New stent graft could fix deadly aortic arch conditions
Disease control Recruiting nowProspective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascen…
Sponsor: Endospan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug cocktail aims to fight Hard-to-Treat prostate cancer
Disease control OngoingThis is a Phase 3, multi-center, randomized, open-label, controlled study designed to evaluate the safety and efficacy of cabozantinib given in combination with atezolizumab versus a second novel hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (…
Phase 3 • Sponsor: Exelixis • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New chemo combo offers hope for kids with tough kidney cancer
Disease control Recruiting nowThis phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens such as …
Phase 2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New combo therapy aims to delay prostate cancer progression
Disease control OngoingThis is the first pilot phase II trial assessing the response of SBRT layered on Darolutamide (BAY1841788) on RPFS and deferring palliative second line systemic therapy in M0CRPC with oligoprogression.
Phase 2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New strategy aims to make targeted therapy work longer for colorectal cancer patients
Disease control OngoingThe study will use previously established doses of panitumumab or cetuximab in the metastatic setting for the treatment of unresectable colorectal cancer (CRC). It is designed to investigate an alternative treatment strategy to maximize the benefit to inhibition of epidermal grow…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Targeted pill aims to halt recurrent ovarian and endometrial cancers
Disease control Recruiting nowThis phase II trial studies how well abemaciclib works in treating patients with ovarian or endometrial cancer that has an activation of the CDK4/6 pathway and that has come back (recurrent). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed fo…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New eye injection aims to reduce treatment burden for diabetic macular edema
Disease control CompletedThis study is a multi-center, open, multiple-dose phase Ib/IIa clinical study evaluating the efficacy and safety of BAT5906 injection in patients with diabetic macular edema. BAT5906's phase I study on w-AMD shows that it is safe from 0.3-4.0 mg, and the higher dose (2.5 mg and 4…
Phase 1/2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC